You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
5 August 2019
Sanofi's Consumer Healthcare business reported worldwide sales up by 1.1% at constant exchange rates in the second quarter of 2019. The company said brand divestments and tightening regulatory requirements, particularly in Europe, had reduced growth by around two percentage points.
23 July 2019
Sanofi has gained exclusive OTC rights to Roche's Tamiflu (oseltamivir) for prevention and treatment of flu in the US.
19 June 2019
Sanofi and Google are creating a virtual Innovation Lab with the aim of "radically transforming how future medicines and health services are delivered by tapping into the power of emerging data technologies".
10 June 2019
Sanofi has announced that Paul Hudson will replace Olivier Brandicourt as chief executive officer from 1 September 2019.
29 April 2019
Sanofi's Consumer Healthcare business reported worldwide sales up by 0.6% at constant exchange rates in the first quarter of 2019. The company said growth in the Emerging Markets region had offset lower sales in Developed Markets and the impact of divesting non-core brands.
27 March 2019
Sanofi Consumer Healthcare aims to "transform the healthcare landscape" in Latin America through a strategic partnership with e-commerce marketplace Rappi.
25 March 2019
Sanofi Consumer Healthcare's Alan Main has been elected chair of the World Self-Medication Industry (WSMI).
11 February 2019
Sanofi's Consumer Healthcare business reported worldwide sales up by 1.9% at constant exchange rates in the fourth quarter of 2018. The Emerging Markets region and the US recorded significant growth but sales in Europe dropped back.
31 January 2019
Sanofi Consumer Healthcare is working with Startup Creasphere, a digital health innovation hub that brings together established healthcare companies and startups.
5 November 2018
Sanofi's Consumer Healthcare business reported worldwide sales up by 4.1% at constant exchange rates in the third quarter of 2018. Olivier Brandicourt, Sanofi's chief executive officer, said that there had been "balanced growth across all geographies and key categories".